ARCHIVES

DCT Advisors Approve Grants Program For Trials Of BRMs

This article is from The Cancer Letter archive.

Vol. 21 No. 10 | March 10, 1995

Download PDF Visit The Full Archive

Related Articles

Was Dr. Bunn Insensitive Or Just Efficient? FDA Imbroglio Points To Larger Problems

November 10, 1995

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

DePinho’s Wife Was Briefed on AVEO Data 11 Days Before He Touted Stock on CNBC

September 13, 2013

NRC Reports Says NIH Security Of nuclear Materials a Problem

January 5, 1996

Study: Ibrutinib Lowers IgM, Bone Marrow Disease Burden

July 26, 2013

Committee Kills Pay Raise Bill; Rauscher Probably Will Resign

September 17, 1976